Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

US Patent 11944625 · Granted Apr 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Small molecule target bromo/acetyl proteins and uses thereof2025
Compounds, compositions, and methods for protein degradation2025
Compounds and methods for treating cancer2025
Compounds and methods for treating cancer2025
Acetylation writer inhibitor development and uses thereof2025
DOT1L degraders and uses thereof2025
RGMC-selective inhibitors and use thereof2025
Calmodulin inhibitors for the treatment of ribosomal disorders and ribosomopathi2025
Methods for inducing hematopoietic stem cell specificity2025
Endothelial cell factors and methods thereof2024
Chromobox protein inhibitors and uses thereof2024
Chromobox protein inhibitors and uses thereof2024